A RECENT REVIEW ON: CORONAVIRUS DISEASE 2019

Authors

  • MANDEEP SINGH Department of Pharmaceutics, Shivalik College of Pharmacy, Nangal, Punjab, India. https://orcid.org/0000-0003-2724-1763
  • DHRUV DEV Department of Pharmaceutics, Shivalik College of Pharmacy, Nangal, Punjab, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i7.44547

Keywords:

Coronavirus disease 2019, Transmission process, Symptom, Clinical features, Treatment

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, the capital of China’s Hubei province and has rapidly spread all over the world. Until August 2020, >25 million cases of SARS-CoV-2 infection had been confirmed worldwide, causing >800,000 deaths. This disease was named by the World Health Organization (WHO) as COVID-19. Similar to SARS and Middle East Respiratory Syndrome, which are also caused by corona virus infections, COVID-19 mainly causes severe respiratory system damage; however, it also causes damage to multiple organs, including the gastrointestinal tract, the cardiovascular system and the nervous system. According to the WHO, common signs of infection include fever, cough, and respiratory difficulties like shortness of breath. Serious cases can lead to pneumonia, kidney failure, and even death. The main aim of the present review article was to summarize the current knowledge of COVID-19, such as the transmission process, diagnostic methods, clinical feature pathological characteristics, and treatment measures.

Downloads

Download data is not yet available.

References

Hui DS, Azhar IE, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health d the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264e6.

Chauhan S. Comprehensive review of coronavirus disease 2019 (COVID-19). Biomed J 2020;43:334-40. doi: 10.1016/j.bj.2020.05.023, PMID 32788071

Statement on the Second Meeting of the International Health Regulations. Emergency Committee Regarding the Outbreak of Novel Coronavirus, nCoV. Geneva: World Health Organization; 2005. Available from: https://www.who.int/news-room/detail/30-01- 2020-statement-on-the-secondmeeting- of-the-international-health-regulations-(2005)- emergency-committee-regarding-the-outbreak-of-novel coronavirus-(2019-ncov)

Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J 2020;43:328-33. doi: 10.1016/j.bj.2020.04.007, PMID 32387617

Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Available from: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers [Last accessed on 2020 Apr 15].

Coronavirus.jhu.edu. Mapping 2019- ncov. [Last accessed on 2020 Jan 23].

Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19). A clinical update. Front Med 2020;14:126-35. doi: 10.1007/s11684- 020-0767-8, PMID 32240462

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020;382:727-33.

Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of corona viruses. Trends Microbiol 2016;24:490-502. doi: 10.1016/j.tim.2016.03.003, PMID 27012512

Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol 2017;25:35-48. doi: 10.1016/j.tim.2016.09.001, PMID 27743750

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74. doi: 10.1016/ S0140-6736(20)30251-8, PMID 32007145

Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020;83:217-20. doi: 10.1097/ JCMA.0000000000000270, PMID 32134861

Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020;22:69-71. doi: 10.1016/j.micinf.2020.01.004, PMID 32032682

Sookaromdee P, Wiwanitkit V. Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak. Asian Pac J Trop Med 2020;13:277516.

Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (covid-19): A literature review. J Infect Public Health 2020;13:667-73. doi: 10.1016/j.jiph.2020.03.019, PMID 32340833

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44. doi: 10.1038/s41564-020- 0695-z, PMID 32123347

Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT, et al. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol 2020;92:602-11. doi: 10.1002/jmv.25731, PMID 32104911

da Silva SJ, Silva CT, Guarines KM, Mendes RP, Pardee K, Kohl A, et al. Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect Dis 2020;6:2319-36. doi: 10.1021/ acsinfecdis.0c00274, PMID 32786280

Syed A. Coronavirus: A mini-review. Int J Curr Res Sci 2020;6:8-10.

Chavez S, Long B, Koyfman A, Liang SY. Coronavirus disease (COVID-19): A primer for emergency physicians. Am J Emerg Med 2021;44:220-9. doi: 10.1016/j.ajem.2020.03.036, PMID 32265065

Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathologyof early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15:700-4. doi: 10.1016/j.jtho.2020.02.010

National Health Commission of the People’s Republic of China. Guideline for the Diagnosis and Treatment of COVID-19 Infections (Version 1-7). Beijing, China: National Health Commission of the People’s Republic of China; 2020.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2. doi: 10.1016/S2213- 2600(20)30076-X, PMID 32085846

Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID 19). Available from: http://www.preprints.org/manuscript/202002.0407/ v4.Preprints2020;2020020407https

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. doi: 10.1056/NEJMoa2002032

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13. doi: 10.1016/S0140-6736(20)30211-7, PMID 32007143

Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect Dis. 2020;20:425-34. doi: 10.1016/ S1473-3099(20)30086-4, PMID 32105637

Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. AJR Am J Roentgenol 2020;214:1072-7. doi: 10.2214/AJR.20.22976, PMID 32125873

Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics 2018;38:719-39. doi: 10.1148/rg.2018170048, PMID 29757717

Franquet T, Müller NL, Giménez A, Martínez S, Madrid M, Domingo P. Infectious pulmonary nodules in immunocompromised patients: Usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr 2003;27:461-8. doi: 10.1097/00004728- 200307000-00001, PMID 12886125

Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020;47:1275-80. doi: 10.1007/s00259- 020-04735-9, PMID 32107577

Wu J, Feng LC, Xian XY, Qiang J, Zhang J, Mao QX, et al. Novel coronavirus pneumonia (COVID-19) CT distribution and sign features. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:321-6. doi: 10.3760/ cma.j.cn112147-20200217-00106, PMID 32125131

Coronavirus Outbreak. Available from: https://www.worldometers. info/coronavirus [Last accessed on 2020 Feb 23].

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ 2020;368:m606. doi: 10.1136/bmj.m606, PMID 32075786

Cheng ZJ, Shan J. 2019 novel coronavirus: Where we are and what we know. Infection 2020;48:155-63. doi: 10.1007/s15010-020-01401-y, PMID 32072569

Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, et al. Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Zhonghua Er Ke Za Zhi 2020;58:E008. doi: 10.3760/cma.j.issn.0578-1310.2020.0008, PMID 32062875

Chen F, Liu ZS, Zhang FR, Xiong RH, Chen Y, Cheng XF, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhong hua Er Ke Za Zhi 2020;58:E005.

Zeng LK, Tao XW, Yuan WH, Wang J, Liu X, Liu ZS. First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi 2020;58:E009. doi: 10.3760/cma.j.issn.0578-1310.2020.0009, PMID 32065520

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924, PMID 32081636

Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifesta-tions and potential fecal-oral transmission. Gastroenterology 2020;158:1518-9. doi: 10.1053/j.gastro.2020.02.054, PMID 32142785

Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respi-ratory failure of COVID-19 patients. J Med Virol 2020;92:552-5. doi: 10.1002/ jmv.25728, PMID 32104915

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5, PMID 31986264

Li H, Wang YM, Xu JY, Cao B. Potential antiviral therapeu-tics for 2019 Novel coronavirus. Zhonghua Jie He Hu Xi Za Zhi 2020;43:E002.

MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: The potential role of extra-corporeal membrane oxygenation. JAMA 2020;323:1245-6. doi: 10.1001/ jama.2020.2342, PMID 32074258

Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;20:398-400. doi: 10.1016/S1473-3099(20)30141-9, PMID 32113510

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- an update on the status. Mil Med Res 2020;7:11. doi: 10.1186/s40779-020-00240-0, PMID 32169119

Becker RC. COVID-19 treatment update: Follow the scientific evidence. J Thromb Thrombolysis 2020;50:43-53. doi: 10.1007/ s11239-020-02120-9, PMID 32338320

Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, et al. SARS-CoV-2: Repurposed drugs and novel therapeutic approaches- insights into chemical structure-biological activity and toxicological screening. J Clin Med 2020;9:2084. doi: 10.3390/jcm9072084

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949. doi: 10.1016/j.ijantimicag.2020.105949, PMID 32205204

Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A, Hörner R. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. Int J Antimicrob Agents 2020;55:105969. doi: 10.1016/j. ijantimicag.2020.105969, PMID 32278811

Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of COVID-19 Infection in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 2020;35:e79. doi: 10.3346/jkms.2020.35.e79, PMID 32056407

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;58:1131-4. doi: 10.1515/cclm-2020-0198, PMID 32119647

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: Immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther 2020;5:128. doi: 10.1038/s41392-020-00243-2, PMID 32712629

Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res 2019;105:93-116. doi: 10.1016/bs.aivir.2019.08.002, PMID 31522710

Casadevall A, Pirofski LA. The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases. PLoS Pathog 2015;11:e1004717. doi: 10.1371/journal.ppat.1004717, PMID 25905897

Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020;584:437-42. doi: 10.1038/s41586-020-2456- 9, PMID 32555388

Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 vaccine race: Challenges and opportunities in vaccine formula-tion. AAPS PharmSciTech 2020;21:225. doi: 10.1208/s12249-020-01744-7, PMID 32761294

Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med 2020;46:3-16. doi: 10.3892/ijmm.2020.4596, PMID 32377694

Mcintosh K. coronaviruses: A comparative review. In: Arberw HR, Henlew HP, Jernenk KP, editors. Current Topics in Microbiology and Immunology/Ergebnisse der Mikrobiologie und Immunitatsforschung. Vol. 85. Berlin, Heidelberg: Springer; 1974. p. e129.

Hamre D, Procknow JJ. A new virus isolated from the humanrespiratory tract. Proc Soc Exp Biol Med 1966;121:190-3. doi: 10.3181/00379727- 121-30734, PMID 4285768

Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005;24;S223e7. doi: 10.1097/01. inf.0000188166.17324.60, PMID 16378050

McKie R. Scientists Trace 2002 Sars Virus to Colony of Cave-dwelling Bats in China. Available from: https://www.theguardian.com/world/2017/ dec/10/sars-virus-bats-china-severe-acuterespiratory-syndrome

Novel Coronavirus Update e New Virus to be Called MERS-CoV. WH0; 2020. Available from: https://www.WHO.int [Last accessed on 2020 Apr 15].

Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonoticbeta coronavirus causing SARS-like disease. Clin Microbiol Rev 2015;28:465-e522.

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41:145-51. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003, PMID 32064853

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. doi: 10.1001/jama.2020.2648, PMID 32091533

Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: A review. J Intern Med 2021;289:450-62. doi: 10.1111/ joim.13184, PMID 33020988

Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA statement addresses concerns re: Using RAAS Antagonists in COVID-19. J Card Fail 2020;26:370. doi: 10.1016/j.cardfail.2020.04.013, PMID 32439095

Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R. Lung fibrosis: An undervalued finding in COVID-19 pathological series. Lancet Infect Dis 2021;21:e72. doi: 10.1016/S1473-3099(20)30582-X, PMID 32735785

Atabakhsh V. Social Distancing: 6 Ways to Help Older Adults Change their Routines. Australia: The Conversation; 2020.

Beachum L. Experts Debate Whether “Senior-only” Shoppinghours Protect the Elderly from Getting COVID19. Washington Post. Available from: https://www.washingtonpost.com/business/2020/03/17/snior-only-shopping-coronavirus [Last accessed on 2020 Mar 29].

FitzGerald GA. Misguided drug advice for COVID-19. Science 2020;367:1434.

US Food and Drug Administration. FDA Advises Patients on Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) for COVID-19. Silver Spring, MD: US Food and Drug Administration; 2020. Available from: https:// www.fda.gov/drugs/drugsafety-and-availability/fda-advisespatients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19.

Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond) 2017;31:828-45. doi: 10.1038/eye.2016.298, PMID 28282061

Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003;3:977-81. doi: 10.1034/j.1600-6143.2003.00197.x, PMID 12859532

American College of Surgeons. COVID-19 and Surgery: Clinical Issues and Guidance. Chicago: American College of Surgeons; 2020. Available from: https://www.facs.org/covid-19/clinical-guidance

Impelli M. Italian Man with Coronavirus who Hid Symptoms to Get Rhinoplasty Facing 12 Years in Prison. New York: Newsweek; 2020.

Elizabeth HB. Doctors are being Forced to Ration Care. Don’t Blame Them. Blame Decades of Poor u S. Policy [Opinion]. Available from: https://www.newsweek.com/2020/04/24/doctorsare-being-forced-ration-care-dont-blame-them-blamedecades-poor-us-policy-opinion-1496030.html [Last accessed on 2020 Apr 06].

WHO. Coronavirus disease 2019 (COVID-19) situation report-51. Available from: https://www.who.int/docs/defaultsource/coro¬naviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?s¬fvrsn=1ba62e57_6. [Last accessed on 2020 Mar 14].

WHO-Afro. More than 15 countries in Africa report COVID-19 cases: WHO-Africa. Available from: https://www.afro.who.int/news/more-15- countries-africa-report-covid-19-cases. [Last accessed on 2020 Mar 15].

Published

07-07-2022

How to Cite

SINGH, M., and D. DEV. “A RECENT REVIEW ON: CORONAVIRUS DISEASE 2019”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 7, July 2022, pp. 17-24, doi:10.22159/ajpcr.2022.v15i7.44547.

Issue

Section

Review Article(s)

Most read articles by the same author(s)